Jack Higgins

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Founded in 1947 by Oscar Gruss and Emanuel Gruss, Oscar Gruss & Son, Inc. is a full-service broker/dealer located in New York City. The firm offers focused independent research and trading and execution services focusing particularly on special situations and convertibles. They conduct business with major Israeli institutional clients who execute trades in U.S. equities and options. Oscar Gruss & Son also maintains a trading desk in New York solely dedicated to European investors. The firm is a member of the NYSE and the SIPC.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Cortria Corp. operates as a clinical-stage pharmaceutical company that focuses on developing medicines to fight cardiovascular disease. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in August 2005 and is headquartered in Needham, MA.

Brand & Services Acquisition Corp. operates as a blank check company. The company does not have any specific business combination under consideration or contemplation. It was formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase or other similar business combination, one or more operating businesses. The company was founded on February 14, 2007 and is headquartered in Ft. Lauderdale, FL.

SVB Leerink Holdings LLC operates as an investment bank holding company with interest in investment services. The firm provides equity research, institutional sales and trading, corporate finance and strategic advisory services. The company was founded in 1995 and is headquartered in Boston, MA.

TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA.

Plastron Acquisition Corp. IV operates as a development stage company. It was formed as a vehicle to pursue a business combination through the acquisition of or merger with an operating business. The company was founded on June 22, 2011 and is headquartered in New York, NY.

Plastron Acquisition Corp. III operates as a development stage company. It was formed as a vehicle to pursue a business combination through the acquisition of or merger with an operating business. The company was founded on May 24, 2011 and is headquartered in New York, NY.

Committed Capital Acquisition Corp. III operates as a development stage company. The firm was organized for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, exchangeable stock transaction or other similar business transaction. The company was founded by Michael Rapoport and Philip R. Wagenheim on May 18, 2011 and is headquartered in New York, NY.

Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach.

Aju IB Investment Co., Ltd. (Aju IB) is the venture capital subsidiary of AJU Capital Co., Ltd founded in 1974 by Korea Technology Development Corp. The firm is headquartered in Seoul, Korea.

Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ.

Cyanco Holding Corp. supplies products to the mining industries. The company was founded in 2008 and is headquartered in Reno, NV.

Signa Chemistry develops stabilized reactive metals.

Cyanco Corp. supplies commercial mining explosives. It offers liquid and solid sodium cyanide. The firm offers its products to gold mines. The company was founded in 1988 and is headquartered in Reno, NV.

Great Oaks Venture Capital BZ LLC (Great Oaks Venture Capital) is a venture capital firm founded in 2005 by Andrew K. Boszhardt Jr. The firm is headquartered in New York.

Cyanco International LLC engages in mining solid sodium cyanide. The company is headquartered in Pearland, TX.

Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom.

Research Bridge Partners (Research Bridge Partners) is a venture capital firm founded in 2016 by Reid Hoffman. The firm is headquartered in Austin, Texas.

Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX.

Just Another Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York, NY.

Rocket Global Acquisition Corp. operates as a blank check company. The firm was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated on February 9, 2021 and is headquartered in New York, NY.

Hydrobuilder Holdings LLC is a leading omnichannel platform in the hydroponics, CEA, and specialty agriculture industry. The private company is based in the United States, with a retail footprint in four states and commercial warehouse direct capabilities in 17 states. The American company serves a wide range of customers, from hobbyists to large commercial growers, through its online, retail, and warehouse direct channels. These companies include Greencoast, Hydrobuilder.com, Elevated Equipment and Supply, and Way to Grow. Hydrobuilder Holdings was founded in October 2020 and has acquired four market-leading companies across different sales channels and geographies. The CEO of Hydrobuilder Holdings is Markus Alan Hockenson.

Enavate Sciences is a platform created by Patient Square Capital to support therapeutic companies in advancing medicines and enabling technologies to address patient needs. The company is based in Delaware. Enavate strives to empower a diverse portfolio of therapeutic companies to accelerate innovation through capital support and operational experience. James P. Boylan has been the CEO of the American company since 2022.

Zenas Pharma, Inc. is an American pharmaceutical company that is focused on developing a portfolio of first- and autoimmune therapeutics to address areas of high unmet medical need. The company is located in the US. The company's lead product candidate, obexelimab (zb012), is a novel bifunctional antibody with first-in-class potential that inhibits B-cell lineages that express CD19.